Your browser doesn't support javascript.
loading
In vitro analysis of factors influencing CYP1A2 expression as potential determinants of interindividual variation.
Xie, ChengHui; Pogribna, Marta; Word, Beverly; Lyn-Cook, Lascelles; Lyn-Cook, Beverly D; Hammons, George J.
Afiliación
  • Xie C; Division of Biochemical Toxicology FDA/National Center for Toxicological Research Jefferson Arkansas 72079.
  • Pogribna M; Division of Biochemical Toxicology FDA/National Center for Toxicological Research Jefferson Arkansas 72079.
  • Word B; Division of Biochemical Toxicology FDA/National Center for Toxicological Research Jefferson Arkansas 72079.
  • Lyn-Cook L; Division of Biochemical Toxicology FDA/National Center for Toxicological Research Jefferson Arkansas 72079.
  • Lyn-Cook BD; Division of Biochemical Toxicology FDA/National Center for Toxicological Research Jefferson Arkansas 72079.
  • Hammons GJ; Division of Biochemical Toxicology FDA/National Center for Toxicological Research Jefferson Arkansas 72079.
Pharmacol Res Perspect ; 5(2): e00299, 2017 Apr.
Article en En | MEDLINE | ID: mdl-28357125
ABSTRACT
Individual differences in drug metabolism contribute to interindividual variation that characterizes responses to drugs and risk in exposure to foreign chemicals. Large individual differences are found in expression levels of CYP1A2, a major drug-metabolizing enzyme. Underlying causes for this variation are not well understood. Several factors, including tobacco smoking, consumption of cruciferous vegetables, and sex, have been associated with modulating CYP1A2 expression. To understand factors regulating expression of CYP1A2 in establishing a causal relationship, this study examined effects of cigarette smoke condensate (CSC), indole-3-carbinol (I3C), and 17ß-estradiol (estradiol) on CYP1A2 expression in in vitro systems using human liver and lung cells. Treatment with CSC (2-25 µg/mL) significantly increased levels of CYP1A2 in six cell lines examined, in a concentration- and time-dependent manner. Fold changes in expression levels relative to controls varied among cell lines. CYP1A2 enzymatic activity also increased with CSC exposure. Treatment of H1299 and HepB3 cells with dietary agent I3C (50 and 100 µmol/L) increased CYP1A2 expression. In human cell lines H1299 and H1395, treatment with estradiol (10 and 100 nmol/L) significantly reduced expression of CYP1A2. Using ChIP assays, effects of CSC on histone modifications were analyzed. Increases in H3K4me3 and H4K16ac were observed at several segments in the CYP1A2 gene, whereas H3K27me3 decreased, following CSC treatment. These results suggest that CYP1A2 expression is affected epigenetically by CSC. Additional studies will be needed to further establish regulatory mechanisms underlying effects of various environmental, dietary, and endogenous factors on CYP1A2 expression in better predicting individual variation.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Pharmacol Res Perspect Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Pharmacol Res Perspect Año: 2017 Tipo del documento: Article
...